Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Other Working Capital Changes: 2011-2025

Historic Other Working Capital Changes for Aytu Biopharma (AYTU) over the last 15 years, with Jun 2025 value amounting to $5,078.

  • Aytu Biopharma's Other Working Capital Changes rose 104.05% to $4,818 in Q3 2025 from the same period last year, while for Sep 2025 it was $4,818, marking a year-over-year increase of 102.74%. This contributed to the annual value of $5,078 for FY2025, which is 63.12% up from last year.
  • As of FY2025, Aytu Biopharma's Other Working Capital Changes stood at $5,078, which was up 63.12% from $3,113 recorded in FY2024.
  • Aytu Biopharma's Other Working Capital Changes' 5-year high stood at $332,000 during FY2021, with a 5-year trough of $177 in FY2023.
  • For the 3-year period, Aytu Biopharma's Other Working Capital Changes averaged around $2,789, with its median value being $3,113 (2024).
  • Per our database at Business Quant, Aytu Biopharma's Other Working Capital Changes slumped by 98.70% in 2023 and then soared by 1,658.76% in 2024.
  • Over the past 5 years, Aytu Biopharma's Other Working Capital Changes (Yearly) stood at $332,000 in 2021, then tumbled by 95.89% to $13,642 in 2022, then crashed by 98.70% to $177 in 2023, then skyrocketed by 1,658.76% to $3,113 in 2024, then skyrocketed by 63.12% to $5,078 in 2025.